Skip to content
zameds

Rabeprazole

Sold as Pariet, Rabemed, Acifix, Baprez otc, Baprez ec, Rabeprazole SPEC, Rabaci, Maklorab, Ulcopraz, Aciphex

Loading the molecular structure
C18H21N3O3S359.40 g/mol

2-[[4-(3-Methoxypropoxy)-3-methyl-2-pyridinyl]methylsulfinyl]-1H-benzimidazole

Drag to rotate. Structure from PubChem CID 5029.

Background

Loading...
Loading Wikipedia summary

Registration

Applicants
7
Registrations
18

Applicants and registrations

ApplicantBrandsDosagesRegistrationsScheduleLeaflets
Janssen Pharmaceutica (Pty) Ltd2 of 4 cancelledPariet, Aciphex10 mg, 20 mg320614, 330206, A390468, A390469Not determinedNone
Sandoz South Africa (Pty) LtdRabemed10, 20440597, 440598Not determinedNone
Abex Pharmaceutica (Pty) LtdAcifix10, 20471283, 471284Not determinedNone
Ranbaxy Pharmaceutical (Pty) LtdBaprez otc, Baprez ec20481095, 481096Not determinedNone
Specpharm (Pty) LtdRabeprazole SPEC10, 20490955, 490956Not determinedNone
Astral Pharma (Pty) LtdRabaci10, 20509022, 509023Not determinedNone
Macleods Pharmaceuticals SA (Pty) LtdMaklorab, Ulcopraz10, 20560621, 560622, 560623.621, 560624.622Not determinedNone

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Pariet 20 MG

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 20,0 mg

20 mg32061432/11.4.3/0614RegisteredNot determinedNone
Pariet 10 MG

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 10,0 mg

10 mg33020633/11.4.3/0206RegisteredNot determinedNone
Rabemed 10

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 10,0 mg

1044059744/11.4.3/0597RegisteredNot determinedNone
Rabemed 20

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 20,0 mg

2044059844/11.4.3/0598RegisteredNot determinedNone
Acifix 10

Each tablet contains :10,0 mg RABEPRAZOLE SODIUM EQUIVALENT TO RABEPRAZOLE 9,40 mg

1047128347/11.4.3/1283RegisteredNot determinedNone
Acifix 20

EACH TABLET CONTAINS: 20,0 mg RABEPRAZOLE SODIUM EQUIVALENT TO RABEPRAZOLE 18,80 mg

2047128447/11.4.3/1284RegisteredNot determinedNone
Baprez otc

Each centeric coated tablet contains: Rabeprazole sodium equivalent to Rabeprazole 9,42 mg

Not listed48109548/11.4.3/1095RegisteredNot determinedNone
Baprez 20 ec

Each enteric coated tablet contains: Rabeprazole sodium equivalent to rabeprazole 18,85 mg

2048109648/11.4.3/1096RegisteredNot determinedNone
Rabeprazole 10 SPEC

Each tablet contains 10,0 mg RABEPRAZOLE SODIUM EQUIVALENT TO RABEPRAZOLE 9,42 mg

1049095549/11.4.3/0955RegisteredNot determinedNone
Rabeprazole 20 SPEC

Each tablet contains 20,0 mg RABEPRAZOLE SODIUM EQUIVALENT TO RABEPRAZOLE 18,85 mg

2049095649/11.4.3/0956RegisteredNot determinedNone
Rabaci 10

Each tablet contains 10,0 mg RABEPRAZOLE SODIUM EQUIVALENT TO RABEPRAZOLE 9,40 mg

1050902250/11.4.3/9022RegisteredNot determinedNone
Rabaci 20

Each tablet contains 20,0 mg RABEPRAZOLE SODIUM EQUIVALENT TO RABEPRAZOLE 18,80 mg

2050902350/11.4.3/9023RegisteredNot determinedNone
Maklorab 10

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 10,0 mg

1056062156/11.4.3/0621RegisteredNot determinedNone
Maklorab 20

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 20,0 mg

2056062256/11.4.3/0622RegisteredNot determinedNone
Ulcopraz 10

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 10,0 mg

10560623.62156/11.4.3/0623.621RegisteredNot determinedNone
Ulcopraz 20

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 20,0 mg

20560624.62256/11.4.3/0624.622RegisteredNot determinedNone
Aciphex 10

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 10,0 mg

10A390468A39/11.4.3/0468CancelledNot determinedNone
Aciphex 20

EACH TABLET CONTAINS RABEPRAZOLE SODIUM 20,0 mg

20A390469A39/11.4.3/0469CancelledNot determinedNone

Regulatory status

This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.

Listings for this ingredient that could not be applied to this product

  • S4: Rabeprazole

    • except when intended for the temporary short term relief of heartburn and hyperacidity, subject to-
    • maximum daily dose of 10 milligrams;
    • maximum treatment period of 14 days. (S2)

    Consolidated Schedules 06 July 2026, lines 7702 to 7707

  • S2: Rabeprazole

    • when intended for the temporary short term relief of heartburn and hyperacidity, subject to-
    • maximum daily dose of 10 milligrams;
    • maximum treatment period of 14 days. (S4)

    Consolidated Schedules 06 July 2026, lines 2619 to 2623

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Research articles

Loading...
Loading PubMed articles